Bioventix (BVXP) — Working Capital to Net Assets Ratio
Bioventix (BVXP) has a Working Capital to Net Assets ratio of 92.4% as of December 2025. Working capital of GBX10.20 Million (current assets of GBX12.20 Million minus current liabilities of GBX1.99 Million) is measured against net assets of GBX11.04 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See BVXP cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bioventix Working Capital to Net Assets (2011–2025)
This chart shows how Bioventix's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 92.4%, reflecting working capital of GBX10.20 Million against net assets of GBX11.04 Million GBX. For the complete balance sheet picture, see BVXP asset base.
Annual Working Capital to Net Assets for Bioventix (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bioventix from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore Bioventix (BVXP) investment intensity to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 92.8% | GBX10.72 Million | GBX11.55 Million | GBX12.03 Million | GBX1.31 Million | ▲ +0.3 pp |
| 2024 | 92.5% | GBX11.10 Million | GBX12.00 Million | GBX12.83 Million | GBX1.73 Million | ▲ +2.1 pp |
| 2023 | 90.3% | GBX10.90 Million | GBX12.06 Million | GBX12.10 Million | GBX1.20 Million | ▲ +1.0 pp |
| 2022 | 89.3% | GBX10.56 Million | GBX11.82 Million | GBX11.81 Million | GBX1.25 Million | ▲ +1.0 pp |
| 2021 | 88.4% | GBX10.44 Million | GBX11.82 Million | GBX11.45 Million | GBX1.01 Million | ▼ -1.4 pp |
| 2020 | 89.8% | GBX11.24 Million | GBX12.52 Million | GBX11.97 Million | GBX728.63K | ▼ -2.2 pp |
| 2019 | 91.9% | GBX9.95 Million | GBX10.83 Million | GBX10.71 Million | GBX756.57K | ▼ -1.1 pp |
| 2018 | 93.1% | GBX10.25 Million | GBX11.01 Million | GBX11.09 Million | GBX838.43K | ▼ -0.7 pp |
| 2017 | 93.8% | GBX9.52 Million | GBX10.14 Million | GBX9.74 Million | GBX219.94K | ▼ -0.2 pp |
| 2016 | 94.0% | GBX7.71 Million | GBX8.21 Million | GBX8.26 Million | GBX549.91K | ▲ +1.1 pp |
| 2015 | 92.9% | GBX6.12 Million | GBX6.58 Million | GBX6.41 Million | GBX297.53K | ▲ +0.9 pp |
| 2014 | 92.0% | GBX4.82 Million | GBX5.24 Million | GBX5.35 Million | GBX530.91K | ▲ +2.5 pp |
| 2013 | 89.5% | GBX3.76 Million | GBX4.20 Million | GBX4.06 Million | GBX299.74K | ▲ +3.4 pp |
| 2012 | 86.1% | GBX2.87 Million | GBX3.34 Million | GBX3.08 Million | GBX206.83K | ▲ +4.5 pp |
| 2011 | 81.6% | GBX2.18 Million | GBX2.68 Million | GBX2.37 Million | GBX184.38K | — |